Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial

Bibliografiske detaljer
Main Authors:	Minassian, A, Silk, S, Poulton, I, Mitton, C, Payne, R, Rawlinson, T, Barrett, J, Baker, M, Ramon, R, Lopez, F, Edwards, N, Ellis, K, Nielsen, C, Quinkert, D, Barfod, L, Miura, K, Diouf, A, Folegatti, P, Silman, D, Datoo, M, Smith, R, Berrie, E, Morelle, D, Lievens, M, Noe, A, Diggs, C, Soisson, L, Ashfield, R, Long, C, Nugent, F, Lawrie, A, Draper, S
Format:	Conference item
Udgivet:	American Society of Tropical Medicine and Hygiene 2018

Lignende værker

Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
af: Minassian, AM, et al.
Udgivet: (2017)

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
af: Minassian, AM, et al.
Udgivet: (2021)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
af: Folegatti, P, et al.
Udgivet: (2019)

In silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccinees
af: Terry, F, et al.
Udgivet: (2018)

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
af: Folegatti, PM, et al.
Udgivet: (2020)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
af: Folegatti, P, et al.
Udgivet: (2019)

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: safety and parasite growth dynamics
af: Salkeld, J, et al.
Udgivet: (2022)

Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine chad63-mva rh5 in a phase ia clinical trial
af: Payne, R, et al.
Udgivet: (2017)

Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
af: Folegatti, PM, et al.
Udgivet: (2019)

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
af: Folegatti, PM, et al.
Udgivet: (2020)

A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
af: Porter, D, et al.
Udgivet: (2011)

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
af: Porter, D, et al.
Udgivet: (2011)

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
af: Thompson, F, et al.
Udgivet: (2008)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
af: Folegatti, P, et al.
Udgivet: (2021)

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
af: Jo Salkeld, et al.
Udgivet: (2022-08-01)

Quantum black holes in Type-IIA String Theory
af: Bueno, P, et al.
Udgivet: (2012)

Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
af: Payne, R, et al.
Udgivet: (2017)

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development
af: Mertens, JE, et al.
Udgivet: (2024)

MANEJO DEL CÁNCER CERVICOUTERINO IB2-IIA
af: José A Solis C
Udgivet: (2004-01-01)

Vaccines against Ebola virus
af: Venkatraman, N, et al.
Udgivet: (2017)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
af: Rowland, R, et al.
Udgivet: (2012)

Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
af: Nielsen, C, et al.
Udgivet: (2021)

A geometric dual of F-maximization in massive type IIA
af: Couzens, C, et al.
Udgivet: (2024)

A geometric dual of F-maximization in massive type IIA
af: Couzens, C, et al.
Udgivet: (2024)

Detection of HTLV-IIa in blood donors in an urban area of the Amazon Region of Brazil (Belém, PA)
af: Ishak R., et al.
Udgivet: (1998-01-01)

Prime and target immunization protects against liver-stage malaria in mice
af: Gola, A, et al.
Udgivet: (2018)

Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
af: Jin, J, et al.
Udgivet: (2018)

Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 vaccine FMP2.1/AS01
af: Payne, R, et al.
Udgivet: (2016)

On Type IIA AdS3 solutions and massive GK geometries
af: Couzens, C, et al.
Udgivet: (2022)

High level efficacy in humans of a next-generation plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant
af: Venkatraman, N, et al.
Udgivet: (2017)

Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa.
af: Cooke, G, et al.
Udgivet: (2003)

A plethora of Type IIA embeddings for d = 5 minimal supergravity
af: Couzens, C, et al.
Udgivet: (2023)

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
af: R. C. Coombes, et al.
Udgivet: (2022-06-01)

Development of Class IIa Bacteriocins as Therapeutic Agents
af: Christopher T. Lohans, et al.
Udgivet: (2012-01-01)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
af: Pathan, A, et al.
Udgivet: (2012)

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial
af: Folegatti, P, et al.
Udgivet: (2021)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
af: Pedro M. Folegatti, et al.
Udgivet: (2019-05-01)

Myosin IIA and formin dependent mechanosensitivity of filopodia adhesion
af: N. O. Alieva, et al.
Udgivet: (2019-08-01)

Crystal structure of nitrogen regulatory protein IIA from Neisseria meningitidis
af: Sainsbury, S, et al.
Udgivet: (2005)

Outcomes of combination therapy for stage IIA–IIIB cervical cancer
af: D. K. Reyes Santiago, et al.
Udgivet: (2019-02-01)